Risk of reactivation of Hepatitis B with corticosteroids

In a retrospective territory-wide study from Hong Kong patients
who were negative for Hepatitis B surface antigen (HBsAg)
who received corticosteroids were evaluated for the risk
of seroreversion.

Read more